So I agree with you in that it's ugly, and they do take the lion's share of benefit from public research. That said, the public research doesn't run human trial

So I agree with you in that it's ugly, and they do take the lion's share of benefit from public research. That said, the public research doesn't run human trials, scale up, or QC production. Still ugly, still valuable.